Tarsus to Present at Upcoming Investor Conferences streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Now Available – XDEMVY™ (lotilaner ophthalmic solution) 0 25%, the First and Only FDA Approved Treatment for Demodex Blepharitis itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
IRVINE, Calif., Aug. 01, 2023 Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,.
IRVINE, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) (the "Company" or "Tarsus"), whose mission is to focus on unmet needs and apply proven science and new technology to
Tarsus Announces Proposed $100 0 Million Underwritten Public Offering of Shares of its Common Stock itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.